Rxwire
In the news · 48h FDA 35 Eli Lilly 17 Roche 11 Johnson & Johnson 7 Merck & Co. (MSD) 6 AstraZeneca 4 Bayer 2 Sanofi 2
Trials & R&D · first seen 58m ago, updated 58m ago

Beyond GLP-1 injectables, who wins the next phase for obesity drugs?

1 outlet GLP-1 & obesity drugs

Coverage 1 article · 1 outlet

  1. Seeking Alpha Healthcare
    Beyond GLP-1 injectables, who wins the next phase for obesity drugs?